Arkolith/Insider Trading/AXIM/Form 4/A

Huemoeller John Walter II

Chief Executive Officer, DirectorAXIM BIOTECHNOLOGIES, INC. (AXIM) · full profile →Form 4/A · filed Mar 19, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2024Grant(A)250K$250000.00$62.5B30.0M
Mar 15, 2024Grant(A)250K$250000.00$62.5B42.5M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001096906-24-000525) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML